Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Nucleoside/Nucleotide Treatment of Hepatitis B Virus HBeAg-negative Genotype D Patients and Risk of Hepatocellular Carcinoma:Evidence From the CLEO Cohort Study

NCT02025842 is registered in ClinicalTrials.gov with Azienda Ospedaliera San Camillo Forlanini as lead sponsor.

NCT NCT02025842
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02025842 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Nucleoside/Nucleotide Treatment of Hepatitis B Virus HBeAg-negative Genotype D Patients and Risk of Hepatocellular Carcinoma:Evidence From the CLEO Cohort Study
Lead sponsor
Azienda Ospedaliera San Camillo Forlanini
Phase
Observational
Overall status
Completed
Start date
January 31, 2000
Completion date
December 31, 2013
Enrollment
306 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b, hepatocellular carcinoma